Acetabular Component Thickness Does Not Affect Mid-term Clinical Results in Hip Resurfacing
Clinical orthopaedics and related research(2014)
摘要
Background The benefits of using thin acetabular components for hip resurfacing have been shown in terms of bone conservation, but there currently are little data available in the literature addressing the mid-term clinical results of these devices. Questions/purposes We aimed to determine whether thinner acetabular components altered mid-term postoperative clinical scores, complication rates, survivorship, radiographic appearance, and metal ion levels. Methods Two hundred eighty-one patients with unilateral disease received a 5-mm thick acetabular shell and 223 received a 3.5-mm shell. The femoral component implanted in both groups was identical. We compared clinical scores, complication rates, survivorship, radiographic results, and ion levels between these two groups. Results UCLA hip scores were similar (pain, p = 0.0976; walking, p = 0.9571; function, p = 0.9316; activity, p = 0.2085). Complications were higher in the 5-mm group (6.4% versus 1.8%, p = 0.0431). Both groups were similar regarding survivorship (p = 0.3181), cup radiolucency at 5 years (p = 0.107), and metal ion levels (cobalt p = 0.404, chromium p = 0.250). Conclusions With comparable mid-term clinical results, there is no tangible reason to abstain from using the 3.5-mm acetabular component. Level of Evidence Level III, retrospective comparative study. See the Guidelines for Authors for a complete description of levels of evidence.
更多查看译文
关键词
Acetabular Component, Acetabular Shell, Femoral Nerve Palsy, Serum Cobalt, Femoral Component Size
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络